GP Bisson, R Gross, S Bellamy, J Chittams, M … - medicine.plosjournals.org World Health Organization (WHO) guidelines for monitoring HIV-infected
individuals taking combination antiretroviral therapy (cART) in resource-limited
settings recommend using CD4 + T cell (CD4) count changes to monitor ... Cited by 24 - Related articles - Cached - All 18 versions
- ►naima.org.mz [PDF] A Boulle, G Van Cutsem, K Cohen, K … - JAMA, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Rifampicin-based ... Cited by 25 - Related articles - All 12 versions
- ►prsjournal.com BG Gazzard… - HIV medicine, 2008 - pt.wkhealth.com The translation of data into clinical practice is often difficult even with the
best possible evidence (ie two randomized controlled trials) because of trial
design, inclusion criteria and precise surrogate marker endpoints (see ... Cited by 23 - Related articles - All 5 versions
- ►inserm.fr [PDF] S Toure, B Kouadio, C Seyler, M Traore, N … - AIDS, 2008 - journals.lww.com Results: Between May 2004 and February 2007, 10 211 patients started
antiretroviral treatment in 19 clinics (median preantiretroviral treatment CD4
cell count, 123 cells/μl; initial regimen zidovudine-lamivudine-efavirenz, ... Cited by 19 - Related articles - All 10 versions
DR Bangsberg - The Journal of Infectious Diseases, 2008 - UChicago Press Featured in Newsweek "The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the
Control of Avian and Swine Influenzas Eileen Thacker and Bruce Janke Last ... Cited by 16 - Related articles - BL Direct - All 7 versions
DJ Pepper, GA Meintjes, H McIlleron, RJ … - Drug Discovery Today, 2007 - Elsevier Combining drug therapies for dual infection by Mycobacterium tuberculosis and
HIV-1 is made complex by high pill burdens, shared drug toxicities, drug–drug
and drug–disease interactions, immune reconstitution inflammatory ... Cited by 11 - Related articles - All 5 versions
JB Nachega, M Hislop, DW Dowdy, JE Gallant … - Aids, 2008 - journals.lww.com Results: The median follow-up period was 2.0 years (interquartile range
1.2-2.6). Patients started on nevirapine were significantly less likely than
those started on efavirenz to achieve high adherence, whether defined as ... Cited by 9 - Related articles - All 4 versions
JJ Parienti, M Das-Douglas, V Massari, D … - PLoS One, 2008 - pubmedcentral.nih.gov Copyright Parienti et al. This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original ... Cited by 8 - Related articles - All 8 versions
SK Muyingo, AS Walker, A Reid, P Munderi, DM … - JAIDS Journal of Acquired Immune Deficiency …, 2008 - journals.lww.com Sylvia K. Muyingo, MSc,* A. Sarah Walker, PhD,† Andy Reid, MD,‡ Paula
Munderi, MD,* Diana M. Gibb, MD,† Francis Ssali, MD,§ Jonathan Levin, PhD,*
Elly Katabira, MD,k Charlie Gilks, PhD,¶# Jim Todd, MSc,* and the DART ... Cited by 8 - Related articles - All 10 versions
